Company page

Absci Corporation

Absci Corporation, trading under the ticker ABSI, operates in the American market with a market capitalization of approximately $1.16 billion. The company focuses on advancing biopharmaceuticals through its innovative platform, which integrates artificial intelligence and synthetic biology. Absci aims to enhance drug development processes and improve therapeutic outcomes.